Overview

Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Canada, Asia, Europe and USA. The aim of this clinical trial is to investigate the effect and safety of rFXIII on transfusion needs in patients undergoing heart surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Novo Nordisk A/S